Cresset Asset Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Sell |
|
|||||
|
2025
Q1 | $41.6K | Buy |
|
|||||
|
2024
Q4 | $90K | Hold |
|
|||||
|
2024
Q3 | $143K | Hold |
|
|||||
|
2024
Q2 | $116K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $141K | Hold |
|
|||||
|
2023
Q3 | $46.5K | Buy |
|
|||||
|
2023
Q2 | $55K | Buy |
|
|||||
|
2023
Q1 | $35.4K | Sell |
|
|||||
|
2022
Q4 | $268K | Hold |
|
|||||
|
2022
Q3 | $402K | Sell |
|
|||||
|
2022
Q2 | $387K | Buy |
|
|||||
|
2022
Q1 | $1.1M | Buy |
|
|||||
|
2021
Q4 | $1.4M | Buy |
|